Emily Vandenekart

Emily VandenEkart is a Clinical Project Manager and Senior Clinical Project Manager at Akebia Therapeutics since July 2022, overseeing clinical projects from Phase I to III, ensuring adherence to budget, scope, and schedule. Prior experience includes serving as a Clinical Trial Manager at Faraday Pharmaceuticals, Inc., where Emily led clinical trials and collaborated with CROs on service agreements and budgets. Additionally, Emily held roles as Senior Clinical Research Associate and Senior Research Associate at Faraday, leading international studies and developing bioanalytical methods. Early career positions include Research Associate II at TRIA BIOSCIENCE CORP., Clinical Research Associate and Technologist at Bloodworks Northwest, and Research Associate at IKARIA, Inc. Emily holds an MBA from WGU Washington and a Bachelor of Science in Cellular, Molecular, and Developmental Biology from the University of Washington.